Japan NIH proposal gains momentum but concerns linger
This article was originally published in Scrip
As Japan continues to push ahead with plans to set up a US National Institutes of Health-like "control tower" to oversee and co-ordinate the national health R&D effort, there is still caution in some quarters over aspects of the idea.
You may also be interested in...
New potential topical therapy in dermatitis space set to move towards Japan approval submission based on positive new results.
Japan approval for BTK inhibitor marks new indication but in a small niche market, while another clearance may help extend Latuda's commercial life.
Novel antibody-drug conjugate receives approval in Japan for second-line breast cancer, providing another push to Japanese firm’s strategic plan to build up its oncology operations.